Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

282
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
282
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

96
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
96
Pharmacovigilance01:19

Pharmacovigilance

876
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
876
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

89
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
89
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

64
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
64
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

757
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
757

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DispFormer: A dual attention transformer with denoising for biomedical irregular time series classification.

Journal of biomedical informatics·2026
Same author

A temporal deep learning algorithm for prediction of extubation failures in critical care patients.

Journal of clinical monitoring and computing·2026
Same author

DynaMamba: Multi-scale dynamic interacting Mamba network for irregular clinical time series classification.

Journal of biomedical informatics·2026
Same author

Contextual information contributes to biomedical named entity normalization.

Journal of biomedical informatics·2025
Same author

Self-Supervised Molecular Representation Learning With Topology and Geometry.

IEEE journal of biomedical and health informatics·2024
Same author

Revisiting Drug Recommendation From a Causal Perspective.

IEEE journal of biomedical and health informatics·2024

Related Experiment Video

Updated: Jul 15, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

SHAPE: A Sample-Adaptive Hierarchical Prediction Network for Medication Recommendation.

Sicen Liu, Xiaolong Wang, Jingcheng Du

    IEEE Journal of Biomedical and Health Informatics
    |September 28, 2023
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces SHAPE, a new AI model for medication recommendation in patients with multiple complex conditions. SHAPE improves accuracy by better understanding patient medical histories and visit data.

    More Related Videos

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    261
    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.3K

    Related Experiment Videos

    Last Updated: Jul 15, 2025

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    7.6K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    261
    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.3K

    Area of Science:

    • Medical Informatics
    • Artificial Intelligence in Healthcare
    • Clinical Decision Support

    Background:

    • Medication recommendation for patients with complex multimorbidity is challenging.
    • Existing methods often overlook intra-visit event relationships and variable patient longitudinal data structures.

    Purpose of the Study:

    • To propose a novel Sample-adaptive Hierarchical medicAtion Prediction nEtwork (SHAPE).
    • To address limitations in encoding intra-visit medical events and learning variable-length patient sequences for accurate medication recommendation.

    Main Methods:

    • Developed a compact intra-visit set encoder for visit-level representation.
    • Designed an inter-visit longitudinal encoder for efficient patient-level longitudinal representation.
    • Implemented a soft curriculum learning method to handle variable visit lengths.

    Main Results:

    • The SHAPE model demonstrated superior performance compared to state-of-the-art baselines.
    • Experimental results on a benchmark dataset validate the model's effectiveness.

    Conclusions:

    • SHAPE offers an effective approach for medication recommendation in complex multimorbidity cases.
    • The model's adaptive hierarchical structure and learning strategies improve prediction accuracy and handle data variability.